Cargando…

Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016

By 2050, the world would need to produce 1,250 million tonnes of meat and dairy per year to meet global demand for animal-derived protein at current consumption levels. However, growing demand for protein will not be met sustainably by increasing meat and dairy production because of the low efficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritala, Anneli, Häkkinen, Suvi T., Toivari, Mervi, Wiebe, Marilyn G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645522/
https://www.ncbi.nlm.nih.gov/pubmed/29081772
http://dx.doi.org/10.3389/fmicb.2017.02009
_version_ 1783271909960450048
author Ritala, Anneli
Häkkinen, Suvi T.
Toivari, Mervi
Wiebe, Marilyn G.
author_facet Ritala, Anneli
Häkkinen, Suvi T.
Toivari, Mervi
Wiebe, Marilyn G.
author_sort Ritala, Anneli
collection PubMed
description By 2050, the world would need to produce 1,250 million tonnes of meat and dairy per year to meet global demand for animal-derived protein at current consumption levels. However, growing demand for protein will not be met sustainably by increasing meat and dairy production because of the low efficiency of converting feed to meat and dairy products. New solutions are needed. Single cell protein (SCP), i.e., protein produced in microbial and algal cells, is an option with potential. Much of the recent interest in SCP has focused on the valorisation of side streams by using microorganisms to improve their protein content, which can then be used in animal feed. There is also increased use of mixed populations, rather than pure strains in the production of SCP. In addition, the use of methane as a carbon source for SCP is reaching commercial scales and more protein-rich products are being derived from algae for both food and feed. The following review addresses the latest developments in SCP production from various organisms, giving an overview of commercial exploitation, a review of recent advances in the patent landscape (2001–2016) and a list of industrial players in the SCP field.
format Online
Article
Text
id pubmed-5645522
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56455222017-10-27 Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016 Ritala, Anneli Häkkinen, Suvi T. Toivari, Mervi Wiebe, Marilyn G. Front Microbiol Microbiology By 2050, the world would need to produce 1,250 million tonnes of meat and dairy per year to meet global demand for animal-derived protein at current consumption levels. However, growing demand for protein will not be met sustainably by increasing meat and dairy production because of the low efficiency of converting feed to meat and dairy products. New solutions are needed. Single cell protein (SCP), i.e., protein produced in microbial and algal cells, is an option with potential. Much of the recent interest in SCP has focused on the valorisation of side streams by using microorganisms to improve their protein content, which can then be used in animal feed. There is also increased use of mixed populations, rather than pure strains in the production of SCP. In addition, the use of methane as a carbon source for SCP is reaching commercial scales and more protein-rich products are being derived from algae for both food and feed. The following review addresses the latest developments in SCP production from various organisms, giving an overview of commercial exploitation, a review of recent advances in the patent landscape (2001–2016) and a list of industrial players in the SCP field. Frontiers Media S.A. 2017-10-13 /pmc/articles/PMC5645522/ /pubmed/29081772 http://dx.doi.org/10.3389/fmicb.2017.02009 Text en Copyright © 2017 Ritala, Häkkinen, Toivari and Wiebe. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Ritala, Anneli
Häkkinen, Suvi T.
Toivari, Mervi
Wiebe, Marilyn G.
Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016
title Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016
title_full Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016
title_fullStr Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016
title_full_unstemmed Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016
title_short Single Cell Protein—State-of-the-Art, Industrial Landscape and Patents 2001–2016
title_sort single cell protein—state-of-the-art, industrial landscape and patents 2001–2016
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645522/
https://www.ncbi.nlm.nih.gov/pubmed/29081772
http://dx.doi.org/10.3389/fmicb.2017.02009
work_keys_str_mv AT ritalaanneli singlecellproteinstateoftheartindustriallandscapeandpatents20012016
AT hakkinensuvit singlecellproteinstateoftheartindustriallandscapeandpatents20012016
AT toivarimervi singlecellproteinstateoftheartindustriallandscapeandpatents20012016
AT wiebemarilyng singlecellproteinstateoftheartindustriallandscapeandpatents20012016